| CAR T cell-based immunotherapy for the treatment of glioblastoma L Maggs, G Cattaneo, AE Dal, AS Moghaddam, S Ferrone Frontiers in neuroscience 15, 662064, 2021 | 102 | 2021 |
| Cytokine-induced killer cells kill chemo-surviving melanoma cancer stem cells L Gammaitoni, L Giraudo, M Macagno, V Leuci, G Mesiano, R Rotolo, ... Clinical Cancer Research 23 (9), 2277-2288, 2017 | 38 | 2017 |
| CSPG4-specific CAR. CIK lymphocytes as a novel therapy for the treatment of multiple soft-tissue sarcoma histotypes V Leuci, C Donini, G Grignani, R Rotolo, G Mesiano, E Fiorino, ... Clinical Cancer Research 26 (23), 6321-6334, 2020 | 30 | 2020 |
| B7-H3-targeted CAR T cell activity is enhanced by radiotherapy in solid cancers M Ventin, G Cattaneo, L Maggs, J Jia, S Arya, S Ferrone, X Wang, ... Frontiers in Oncology 13, 2023 | 9 | 2023 |
| Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment Y Wang, DL Drum, R Sun, Y Zhang, F Chen, F Sun, E Dal, L Yu, J Jia, ... Nature Communications 14 (1), 5727, 2023 | 8 | 2023 |
| Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models I Iaia, L Gammaitoni, G Cattaneo, L Giraudo, C Donini, E Fiorino, L Primo, ... Cancers 13 (10), 2302, 2021 | 5 | 2021 |
| CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma L Giraudo, G Cattaneo, L Gammaitoni, I Iaia, C Donini, A Massa, ... Journal of Experimental & Clinical Cancer Research 42 (1), 310, 2023 | 2 | 2023 |
| Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy: A Review M Ventin, G Cattaneo, L Maggs, S Arya, X Wang, CR Ferrone JAMA oncology, 2023 | 2 | 2023 |
| Interplay between B7–H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma G Cattaneo, M Ventin, S Arya, F Kontos, T Michelakos, Y Sekigami, L Cai, ... Cancer Letters, 216713, 2024 | 1 | 2024 |
| Radiation enhances the efficacy of B7-H3 Chimeric Antigen Receptor (CAR) T-cell based immunotherapy for Triple Negative Breast Cancer (TNBC) F Kontos, L Maggs, G Cattaneo, T Michelakos, Y Sekigami, S Ferrone, ... Journal of the American College of Surgeons 231 (4), S40-S41, 2020 | 1 | 2020 |
| Chimeric Antigen Receptor T Cell with an Inducible Caspase 9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting M Ventin, G Cattaneo, S Arya, J Jia, MC Gelmi, Y Sun, L Maggs, ... Clinical Cancer Research, 2024 | | 2024 |
| TBK1 inhibition enhances CAR-T cell efficacy against patient-derived organotypic tumor spheroids L Maggs, Y Sun, G Cattaneo, M Ventin, F Chen, MQ Rasmussen, X Wang, ... Cancer Research 84 (6_Supplement), 4003-4003, 2024 | | 2024 |
| Enhancing CAR T cell-based immunotherapy outcomes in PDAC: Evaluating iC9. B7-H3 CAR T cells in adjuvant, neoadjuvant, and monotherapy settings S Arya, SA Sanatkar, M Ventin, G Cattaneo, C Martin, G Lionetto, J Jia, ... Cancer Research 84 (6_Supplement), 6313-6313, 2024 | | 2024 |
| Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy OY Revach, AM Cicerchia, O Shorer, B Petrova, S Anderson, J Park, ... bioRxiv, 2024 | | 2024 |
| Abstract A021: Adjuvant iC9. B7-H3 CAR T cell-based immunotherapy effectively eradicates local and distant metastases in pancreatic ductal adenocarcinoma S Arya, SA Sanatkar, C Martin, M Ventin, J Jia, G Cattaneo, G Lionetto, ... Cancer Research 84 (2_Supplement), A021-A021, 2024 | | 2024 |
| Adjuvant iC9. B7-H3 CAR T cell-based immunotherapy effectively eradicates local and distant metastases in pancreatic ductal adenocarcinoma S Arya, SA Sanatkar, C Martin, M Ventin, J Jia, G Cattaneo, G Lionetto, ... CANCER RESEARCH 84 (2), 2024 | | 2024 |
| 239 CSPG4-targeted CAR T cells demonstrate potent antitumor activity in an orthotopic murine model of anaplastic thyroid cancer G Cattaneo, M Ventin, VR Vantaku, S Arya, J Jia, L Maggs, X Wang, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 561 Targeting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy OY Revach, A Cicerchia, M Sade-Feldman, S Anderson, B Petrova, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 317 B7-H3-targeted CAR T cell with an inducible caspase 9 suicide gene effectively eradicates uveal melanoma liver metastases M Ventin, G Cattaneo, J Jia, S Arya, L Maggs, Y Sun, GM Boland, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| CSPG4-specific CAR. CIK lymphocyte-based immunotherapy to eliminate HLA class I-defective melanoma tumors G Cattaneo, L Giraudo, L Gammaitoni, I Iaia, F Carnevale-Schianca, ... Cancer Research 82 (12_Supplement), 2812-2812, 2022 | | 2022 |
